BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34705580)

  • 1. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
    Li M; Shi M; Xu Y; Qiu J; Lv Q
    Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
    Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
    BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
    Maitituoheti M; Keung EZ; Tang M; Yan L; Alam H; Han G; Singh AK; Raman AT; Terranova C; Sarkar S; Orouji E; Amin SB; Sharma S; Williams M; Samant NS; Dhamdhere M; Zheng N; Shah T; Shah A; Axelrad JB; Anvar NE; Lin YH; Jiang S; Chang EQ; Ingram DR; Wang WL; Lazar A; Lee MG; Muller F; Wang L; Ying H; Rai K
    Cell Rep; 2020 Oct; 33(3):108293. PubMed ID: 33086062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.
    Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z
    Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H3 lysine 4 methyltransferase KMT2D.
    Froimchuk E; Jang Y; Ge K
    Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
    Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
    Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling.
    Zhang J; Ye Y; Xu Z; Luo M; Wu C; Zhang Y; Lv S; Wei Q
    Biochem Biophys Res Commun; 2023 May; 655():35-43. PubMed ID: 36924677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Histone Methyltransferase KMT2D Attenuates Angiogenesis in the Ischemic Heart by Inhibiting the Transcriptional Activation of VEGF-A.
    Meng XM; Liu SB; Deng T; Li DY; You L; Hong H; Feng QP; Zhu BM
    J Cardiovasc Transl Res; 2023 Oct; 16(5):1032-1049. PubMed ID: 36947365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
    Li N; Gou JH; Xiong J; You JJ; Li ZY
    BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3K4 Methylation Dependent and Independent Chromatin Regulation by
    Lee KY; Chen Z; Jiang R; Meneghini MD
    G3 (Bethesda); 2018 May; 8(5):1829-1839. PubMed ID: 29599176
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wang R; He Y; Wang Y; Xie S
    Front Biosci (Landmark Ed); 2023 Jan; 28(1):17. PubMed ID: 36722273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for Set1/MLL-related components in epigenetic regulation of the Caenorhabditis elegans germ line.
    Li T; Kelly WG
    PLoS Genet; 2011 Mar; 7(3):e1001349. PubMed ID: 21455483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
    Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
    Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation.
    Ang SY; Uebersohn A; Spencer CI; Huang Y; Lee JE; Ge K; Bruneau BG
    Development; 2016 Mar; 143(5):810-21. PubMed ID: 26932671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability.
    Sengupta D; Deb M; Kar S; Parbin S; Pradhan N; Patra SK
    Gene; 2019 Jul; 705():22-35. PubMed ID: 31005612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.
    Vallianatos CN; Iwase S
    Epigenomics; 2015; 7(3):503-19. PubMed ID: 26077434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone methylation levels correlate with TGFBIp and extracellular matrix gene expression in normal and granular corneal dystrophy type 2 corneal fibroblasts.
    Maeng YS; Lee GH; Choi SI; Kim KS; Kim EK
    BMC Med Genomics; 2015 Nov; 8():74. PubMed ID: 26553048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex.
    McKinnell IW; Ishibashi J; Le Grand F; Punch VG; Addicks GC; Greenblatt JF; Dilworth FJ; Rudnicki MA
    Nat Cell Biol; 2008 Jan; 10(1):77-84. PubMed ID: 18066051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.
    Li SS; Jiang WL; Xiao WQ; Li K; Zhang YF; Guo XY; Dai YQ; Zhao QY; Jiang MJ; Lu ZJ; Wan R
    World J Gastrointest Oncol; 2019 Aug; 11(8):599-621. PubMed ID: 31435462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
    Alam H; Tang M; Maitituoheti M; Dhar SS; Kumar M; Han CY; Ambati CR; Amin SB; Gu B; Chen TY; Lin YH; Chen J; Muller FL; Putluri N; Flores ER; DeMayo FJ; Baseler L; Rai K; Lee MG
    Cancer Cell; 2020 Apr; 37(4):599-617.e7. PubMed ID: 32243837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.